Gene · 249
Papers3,295
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,295
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of Gap Junctional Intercellular Communication Upregulates Pluripotency Gene Expression in Endogenous Pluripotent Muse Cells. | Cells | 2022 | 36078111 | PubTator, text mining | PubMed |
| Physiological Mineralization during In Vitro Osteogenesis in a Biomimetic Spheroid Culture Model. | Cells | 2022 | 36078105 | PubTator, text mining | PubMed |
| Neuronal Guidance Molecules in Bone Remodeling and Orthodontic Tooth Movement. | Int J Mol Sci | 2022 | 36077474 | PubTator, text mining | PubMed |
| Discovery and characterization of heterogeneous and multipotent fibroblast populations isolated from excised cleft lip tissue. | Stem Cell Res Ther | 2022 | 36076255 | PubTator, text mining | PubMed |
| Never-homozygous genetic variants in healthy populations are potential recessive disease candidates. | NPJ Genom Med | 2022 | 36075934 | PubTator, text mining | PubMed |
| Pain and health-related quality of life in patients with hypophosphatasemia with and without ALPL gene mutations. | Front Endocrinol (Lausanne) | 2022 | 36072928 | PubTator, text mining | PubMed |
| The putative mechanistic insights on how SARS-CoV-2 might influence the outcomes in cancer patients. | Exp Hematol Oncol | 2022 | 36071512 | PubTator, text mining | PubMed |
| Msx1+ stem cells recruited by bioactive tissue engineering graft for bone regeneration. | Nat Commun | 2022 | 36064711 | PubTator, text mining | PubMed |
| Exosomes in the tumor microenvironment of sarcoma: from biological functions to clinical applications. | J Nanobiotechnology | 2022 | 36064358 | PubTator, text mining | PubMed |
| Intra-pulpal connective tissue formation and the advanced carious lesion: Is chondrogenesis and heterotopic ossification a response to pulpal inflammation? | Int Endod J | 2022 | 36056458 | PubTator, text mining | PubMed |
| Xanthohumol exerts anti-inflammatory effects in an in vitro model of mechanically stimulated cementoblasts. | Sci Rep | 2022 | 36056072 | PubTator, text mining | PubMed |
| Oral health status of adult hypophosphatasia patients: A cross-sectional study. | J Clin Periodontol | 2022 | 36054522 | PubTator, text mining | PubMed |
| Dentoalveolar Defects of Hypophosphatasia are Recapitulated in a Sheep Knock-In Model. | J Bone Miner Res | 2022 | 36053890 | PubTator, text mining | PubMed |
| Case report: Disease phenotype associated with simultaneous biallelic mutations in ABCA4 and USH2A due to uniparental disomy of chromosome 1. | Front Genet | 2022 | 36051698 | PubTator, text mining | PubMed |
| Usefulness of ultrasonography and elastography in diagnosing oxaliplatin-induced sinusoidal obstruction syndrome. | Int J Clin Oncol | 2022 | 36042137 | PubTator, text mining | PubMed |
| Encapsulated vaterite-calcite CaCO3 particles loaded with Mg2+ and Cu2+ ions with sustained release promoting osteogenesis and angiogenesis. | Front Bioeng Biotechnol | 2022 | 36032705 | PubTator, text mining | PubMed |
| Translating Material Science into Bone Regenerative Medicine Applications: State-of-The Art Methods and Protocols. | Int J Mol Sci | 2022 | 36012749 | PubTator, text mining | PubMed |
| The Effect of the Topmost Layer and the Type of Bone Morphogenetic Protein-2 Immobilization on the Mesenchymal Stem Cell Response. | Int J Mol Sci | 2022 | 36012551 | PubTator, text mining | PubMed |
| Cartilage Oligomeric Matrix Protein, Diseases, and Therapeutic Opportunities. | Int J Mol Sci | 2022 | 36012514 | PubTator, text mining | PubMed |
| Effects of Burosumab Treatment on Two Siblings with X-Linked Hypophosphatemia. Case Report and Literature Review. | Genes (Basel) | 2022 | 36011303 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/249/papers?page=39